Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Paige Gets CE-IVD Mark, UK Regulatory Approval for Breast Cancer Biomarker Software
The software is designed to detect HER2 expression based on protein and mRNA levels on digital images of tissue samples.
Calithera Biosciences Begins Phase II Trial of Mivavotinib in DLBCL
The company will evaluate the drug in a subset of DLBCL patients with non-germinal center B-cell like disease including those with MYD88 or CD79b mutations.
Molecular Tumor Profiling Benefits Pediatric Cancer Patients, Study Finds
A prospective, multicenter study involving 345 children or young adults with cancer suggested tumor panel sequencing can help guide treatment, improve diagnoses, or inform prognoses.
EMA's CHMP Recommends Novartis' Scemblix for TKI-Intolerant Chronic Myeloid Leukemia Patients
The committee recommended the STAMP inhibitor for previously treated Philadelphia chromosome-positive CML patients based on data from the ASCEMBL trial.
MD Anderson, Turning Point Therapeutics Partner to Study Repotrectinib, Elzovantinib
The research will include preclinical and clinical studies of ROS1/NTRK inhibitor repotrectinib and MET inhibitor elzovantinib in several tumor types.